BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Doxorubicin
,
rs7903146
,
ZBTB7A
,
Coagulation
,
Hepatitis
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
eIF 4E
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Translation state array analysis of Mouse embryonic stem cells and embryoid bodies
Breast tumors from screen-detected or true interval patients
Rhabdomyosarcoma cell gene expression in response to infection with enterovirus EV71
Explore Curated Studies Results
Literature
Most Relevant Literature
The distribution of eukaryotic initiation factor 4E after bouts of resistance exercise is altered by…
Therapeutic targeting of eukaryotic initiation factor (eIF) 4E.
Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein L…
Solution-based approach to study binding to the eIF4E cap-binding site using CD spectroscopy.
NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryoti…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
LY2275796 in Advanced Cancer
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia …
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ